Dovonex Scalp
INDICATIONS
Dovonex (calcipotriene solution) Scalp Solution, 0.005%, is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.
DOSAGE AND ADMINISTRATION
Comb the hair to remove scaly debris and after suitably parting, apply Dovonex Scalp Solution, 0.005%, twice daily, only to the lesions, and rub in gently and completely, taking care to prevent the solution spreading onto the forehead. The safety and efficacy of Dovonex Scalp Solution, 0.005%, have been demonstrated in patients treated for eight weeks.
Keep Dovonex Scalp Solution, 0.005%, well away from the eyes. Avoid application of the solution to uninvolved scalp margins. Always wash hands thoroughly after use.
HOW SUPPLIED
Dovonex® (calcipotriene solution) Scalp Solution, 0.005% is available in 60 mL plastic bottles (NDC 0072-1160-06).
STORAGE
Store at controlled room temperature 15° C-25° C (59° F-77° F). Avoid sunlight. Do not freeze.
Bristol-Myers Squibb Company
Distributed by:Bristol-Myers Squibb Company Princeton, NJ 08543 USA
U.S. Patent No. 4,866,048
FDA Rev date: 4/28/05
Generic Name: Calcipotriene Solution
« Previous: Dovonex Scalp - Drug Description
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Health Extras
Psoriasis Relief
Until now, there's been no truly effective drug treatment for psoriasis. But an arthritis drug is showing promising results.See more WebMD Videos »
Dovonex Scalp
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.